Science Explorer Back to mapMap
Discussion
Research facility · Strasbourg · France

Cancéropôle Est

Research works
2
▲ 42% vs 2018-21
Citations
43
28.3 per fractional work
Top-10% rate
23.4%
all institutions 10.0%
Open access
56%
world 40%
International
40%
world 18%

Not ranked overall: Cancéropôle Est is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cancéropôle Est work in?

In all years, 53% of research at Cancéropôle Est is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (27%), Agricultural and Biological Sciences (7%).

Life Sciences40%Physical Sciences7%Health Sciences53%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine146.7%
    2. Veterinary06.7%
    1. Biochemistry, Genetics and Molecular Biology026.7%
    2. Agricultural and Biological Sciences06.7%
    3. Immunology and Microbiology06.7%
    1. Environmental Science06.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Cancéropôle Est?

The most cited paper from Cancéropôle Est is "The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression" (Federica Babbio, Christian Pistore, Laura Curti et al., 2012), with 137 citations. Next come "The PHD Domain of Np95 (mUHRF1) Is Involved in Large-Scale Reorganization of Pericentromeric Heterochromatin" (69) and "Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty" (43).

Most cited papers
#PaperReleasedCitations
1 The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression Federica Babbio, Christian Pistore, Laura Curti et al. · Oncogene 13 Feb 2012 137
2 The PHD Domain of Np95 (mUHRF1) Is Involved in Large-Scale Reorganization of Pericentromeric Heterochromatin Roberto Papait, Christian Pistore, Ursula Grazini et al. · Molecular Biology of the Cell Open access 28 May 2008 69
3 Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty Déwi Vernerey, Amélie Anota, Pierre Vandel et al. · BMC Geriatrics Open access 17 Nov 2016 43
4 Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma Stefano Chong Hun Kim et al. · Therapeutic Advances in Medical Oncology Open access 2020 34
5 A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotévi et al. · Frontiers in Oncology Open access 19 Jul 2022 28
All 17 most cited papers, with filters and sorting

Which research topics does Cancéropôle Est publish most on?

By volume in 2022-now: Colorectal and Anal Carcinomas, Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics and Immune Cell Function and Interaction.

  1. 1 Colorectal and Anal Carcinomas Surgery 0 works
  2. 2 Pancreatic and Hepatic Oncology Research Oncology 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 Immune Cell Function and Interaction Immunology 0 works
  5. 5 Viral-associated cancers and disorders Oncology 0 works
  6. 6 Hidradenitis Suppurativa and Treatments Dermatology 0 works
  7. 7 Urinary and Genital Oncology Studies Surgery 0 works
  8. 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  9. 9 Cervical Cancer and HPV Research Epidemiology 0 works
  10. 10 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.5%not open44.5%

World: 40% of research is openly available.

with international co-authors39.5%domestic only60.5%

World: 18% is written across borders.

How has Cancéropôle Est's research output changed?

Output in 2022-2025 was 42% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Strasbourg

All research institutions in Strasbourg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cancéropôle Est. Posts are plain text and can be reported.